Actinium Pharmaceuticals ... (ATNM)

AI Score

Unlock

1.79

-0.10 (-5.29%)

At close: Mar 28, 2025, 3:59 PM

1.80

0.35%

After-hours: Mar 28, 2025, 07:55 PM EDT

Actinium Pharmaceuticals Balance Sheet Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06
Cash & Equivalents	76.68M	108.91M	77.83M	63.56M	9.25M	13.67M	17.4M	20.52M	25.64M	6.71M	5.53M	5.62M	150.00	150.00	2.12K	2.22K	6.43K	466.00
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	11.35K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	302K	n/a	391K	391.33K	49.86K	49.86K	49.86K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	313K	n/a	-639K	50K	49.86K	391.13K	390.94K	n/a	n/a	34.73K	n/a	-3.01K	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	237.83K	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.59M	2.03M	1.92M	1.36M	785.72K	656.3K	439.32K	1.87M	838.2K	699.85K	431.03K	334.29K	257.63K	n/a	n/a	n/a	n/a	n/a
Total Current Assets	78.26M	110.94M	79.75M	64.92M	10.09M	14.33M	17.84M	22.39M	26.48M	7.41M	5.75M	5.79M	150.00	150.00	2.12K	2.22K	6.43K	466.00
Property-Plant & Equipment	2.87M	2.95M	639K	1.03M	1.14M	118.8K	57.35K	88.55K	106.11K	127.7K	13.92K	3.01K	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.18M	3.25M	639K	1.47M	1.58M	559.79K	498.15K	138.41K	106.11K	162.43K	13.92K	3.01K	n/a	n/a	n/a	n/a	n/a	n/a
Total Assets	81.44M	114.19M	80.39M	66.4M	11.67M	14.89M	18.34M	22.53M	26.59M	7.57M	5.77M	5.79M	150.00	150.00	2.12K	2.22K	6.43K	466.00
Account Payables	7.95M	10.13M	5.54M	4.34M	4.6M	5.81M	4.65M	4.19M	1.47M	2.28M	378.95K	897.04K	644.51K	13.69K	13.5K	12.36K	2.36K	3.5K
Deferred Revenue	n/a	35M	998K	-4.34M	-4.6M	-6.06M	n/a	n/a	25K	214.36K	81.19K	31.18K	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	541K	996K	614K	854K	746K	249.24K	n/a	n/a	265.69K	283.55K	157.82K	140K	124.36K	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	-498K	691K	-427K	-367	n/a	15.92K	325.68K	2.87M	6.92M	6.79M	3.61M	-742.56K	22.37K	16.4K	13.99K	1.32K	870.00
Total Current Liabilities	8.49M	10.63M	6.84M	4.77M	5.34M	6.06M	4.67M	4.52M	4.61M	9.49M	7.33M	4.64M	26.31K	36.06K	29.9K	26.35K	3.68K	4.37K
Long-Term Debt	1.57M	2.08M	3K	311K	682K	13.35K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	58.71K	68.51K	49.83K	35.96K	14.5K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	311.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	36.57M	37.08M	3K	311K	682.31K	13.35K	n/a	n/a	n/a	n/a	n/a	n/a	58.17K	58.71K	68.51K	49.83K	35.96K	14.5K
Total Liabilities	45.07M	47.71M	6.84M	5.08M	6.03M	6.08M	4.67M	4.52M	4.61M	9.49M	7.33M	4.64M	84.48K	94.77K	98.41K	76.18K	39.64K	18.87K
Total Debt	2.11M	2.58M	310K	738K	1.43M	262.59K	n/a	n/a	265.69K	283.55K	157.82K	140K	120K	60K	68.51K	49.83K	35.96K	14.5K
Common Stock	28K	26K	22K	18K	164.7K	115.7K	80.07K	55.8K	44.07K	29.97K	24.57K	213.92K	111.55K	111.55K	111.55K	23.1K	23.1K	23.1K
Retained Earnings	-337.58M	-288.76M	-255.75M	-230.97M	-208.76M	-186.86M	-163.15M	-136.55M	-112.23M	-91.2M	-66.52M	-55.74M	-259.76K	-270.05K	-271.73K	-249.4K	-208.64K	-193.84K
Comprehensive Income	n/a	-0.00	-0.00	n/a	0.00	-266.38K	-215.66K	-170.45K	-92.93K	-39.47K	-1.56K	-55.74M	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	36.38M	66.48M	73.55M	61.32M	5.64M	8.81M	13.67M	18.01M	21.97M	-1.92M	-1.56M	1.15M	-84.33K	-94.62K	-96.29K	-73.96K	-33.2K	-18.4K
Total Investments	313K	302K	n/a	391K	391.33K	49.86K	49.86K	49.86K	n/a	11.35K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a